» Articles » PMID: 15973135

Magnetic Resonance Imaging Characteristics of Fibrocystic Change of the Breast

Overview
Journal Invest Radiol
Specialty Radiology
Date 2005 Jun 24
PMID 15973135
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study was to identify magnetic resonance imaging (MRI) characteristics of fibrocystic change (FCC) of the breast.

Materials And Methods: Fourteen patients with a histopathologic diagnosis of solitary FCC of the breast underwent x-ray mammography and MRI of the breast. Three experienced breast imaging radiologists retrospectively reviewed the MRI findings and categorized the lesions on morphologic and kinetic criteria according to the ACR BI-RADS-MRI Lexicon.

Results: The most striking morphologic feature of fibrocystic change was nonmass-like regional enhancement found in 6 of 14 (43%) FCC lesions. Based on morphologic criteria alone, 12 of 14 (86%) lesions were correctly classified as benign. According to analysis of the time-intensity curves, 10 of 14 (71%) FCC lesions were correctly classified as benign.

Conclusion: Although FCC has a wide spectrum of morphologic and kinetic features on MRI, it most often presents as a mass or a nonmass-like regional enhancing lesion with benign enhancement kinetics.

Citing Articles

Magnetic resonance differential analysis for different hormone receptor expression status in HER-2-positive breast cancer.

Zou Z, Huang Y, Zhou Z, Yang Y Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023; 48(1):68-75.

PMID: 36935179 PMC: 10930563. DOI: 10.11817/j.issn.1672-7347.2023.220096.


Imaging and Clinical Features of an Unusual Unilateral Breast Enlargement Diagnosed as Fibrocystic Change: A Case Report.

Kim S, Kim W Am J Case Rep. 2019; 19:1550-1555.

PMID: 30595602 PMC: 6324867. DOI: 10.12659/AJCR.913456.


The Value of Lesion Size as an Adjunct to the BI-RADS-MRI 2013 Descriptors in the Diagnosis of Solitary Breast Masses.

Kawai M, Kataoka M, Kanao S, Iima M, Onishi N, Ohashi A Magn Reson Med Sci. 2017; 17(3):203-210.

PMID: 29213007 PMC: 6039786. DOI: 10.2463/mrms.mp.2017-0024.


Breast Dynamic Contrast Enhanced MRI: Fibrocystic Changes Presenting as a Non-mass Enhancement Mimicking Malignancy.

Milosevic Z, Nadrljanski M, Milovanovic Z, Gusic N, Vucicevic S, Radulovic O Radiol Oncol. 2017; 51(2):130-136.

PMID: 28740447 PMC: 5514652. DOI: 10.1515/raon-2017-0016.


Comparative study of the value of dual tracer PET/CT in evaluating breast cancer.

Tateishi U, Terauchi T, Akashi-Tanaka S, Kinoshita T, Kano D, Daisaki H Cancer Sci. 2012; 103(9):1701-7.

PMID: 22632272 PMC: 7659263. DOI: 10.1111/j.1349-7006.2012.02348.x.